Skip to content

Proton International Brings Proton Beam Therapy to Private Patients in First for London

male patient receiving proton beam therapy in london

Proton International has launched London’s first private proton beam therapy service enabling more people, both from the UK and abroad, to access this extremely advanced, precision-targeted cancer treatment which remains a limited resource for much of the world.

Working in partnership with University College London Hospitals NHS Foundation Trust (UCLH), which is one of the UK’s largest and most highly regarded trusts and home to one of only two NHS proton beam therapy centres in the UK, Proton International London will offer insured, self-pay and sponsored patients access to this globally limited treatment.

In conjunction with UCLH’s first-class clinical teams, Proton International London willstart by offering treatment to private adult patients from home and abroad with cancers on the NHS list of indications. Proton International London will also be offering treatment to children from overseas.

Medical Director of Proton International London and Consultant Clinical Oncologist at UCLH, Dr Beatrice Seddon says:

“This innovative partnership is allowing us at Proton International London to offer proton beam therapy to patients with a range of tumours who will benefit from this precision treatment.

“It is an incredibly exciting time to be able to provide greater access to proton beam therapy, and to the skill and expertise of the UCLH consultants and clinical team, to patients both within the UK and beyond.”

Lois Roberts, UCLH Divisional Manager for Cancer, says:

“We are pleased to be working with Proton International London to deliver PBT to private patients, as well as NHS patients. The investment from Proton International has enabled us to expand our treatment capacity within our PBT centre providing greater flexibility to all patients and staff.”

“Proton International is dedicated to creating access for patients to this important technology,” said Chris Chandler, CEO of Proton International. “Our ability to work with UCLH assures that more citizens from the UK and overseas will have access to a very high-quality cancer treatment programme.”

Proton International London is recognised by all major insurers and has been granted Care Quality Commission (CQC) registration. All accredited oncologists have received extensive proton beam therapy training which is supported by Proton International Centres in the United States.


Share this

Recent articles